61312-52-5

Butanoic acid, 3-oxo-, 1-(4-chlorophenyl)ethyl ester

2-Propanol, 1-[[2-[(2-aminoethyl)amino]ethyl]amino]-3-butoxy-

2-Naphthalenol,6-[2-[[2-[3-fluoro-4-[2-(1-piperidinyl)ethoxy]phenyl]ethyl]methylamino]-4-hydroxyphenyl]-5,6,7,8-tetrahydro-

2-Quinoxalinamine, 5-[[6-[4-(trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-

Butanoic acid,[1,2-dihydro-6-(2-methoxyphenyl)-2,2,4-trimethyl-5-quinolinyl]methylester

2-Naphthalenesulfonamide, N,N-diethyl-3-hydroxy-

2-Thiazolamine, 4-imidazo[1,2-a]pyridin-3-yl-N-(4-methoxyphenyl)-

2-Thiazolamine, 4-[4-(phenylmethoxy)phenyl]-5-(4-pyridinyl)-

2-Quinolinecarboxylic acid,4,8-dihydroxy-6-[[(phenylmethyl)amino]methyl]-

L-Serine, L-leucylglycylglycyl-L-a-aspartyl-

2-Quinolinecarboxylic acid,8-nitro-4-(phenylmethoxy)-6-[3-(phenylmethoxy)-1-propynyl]-, methylester

2-Naphthalenol,6-[2-[[[4-[2-(dimethylamino)-2-methylpropoxy]phenyl]methyl]ethylamino]-4,5-dimethoxyphenyl]-5,6,7,8-tetrahydro-, (6R)-

2-Thiazolamine, 4-(4-pyridinyl)-, dihydrobromide

2-Furancarboxamide,N-[[4-(7-chloro-2,3,4,5-tetrahydro-8-hydroxy-3-methyl-1H-3-benzazepin-1-yl)phenyl]methyl]-N-(phenylmethyl)-

2-Thiazolamine, 4,5-dihydro-N-(4-methoxyphenyl)-,mono(trifluoroacetate)

2-Naphthalenesulfonamide,6-hydroxy-N-(2-hydroxyethyl)-N-methyl-5-[[4-(1-methyl-1-phenylethyl)-2-nitrophenyl]azo]-

2-Quinolinecarboxylic acid,4-(acetylphenylamino)-1-(4-fluorobenzoyl)-1,2,3,4-tetrahydro-,(2R,4R)-rel-

5-Quinolinemethanol,1,2-dihydro-6-[2-methoxy-3-(methoxymethoxy)phenyl]-2,2,4-trimethyl-,5-benzoate

2-Quinolinecarboxylic acid,5,7-dichloro-1,2,3,4-tetrahydro-4-(4-methylphenyl)-

2-Naphthalenesulfonamide,N-[3-[3-(diethylamino)propyl]-1H-indol-5-yl]-

2-Naphthalenesulfonamide, N-(1,1-dimethylethyl)-

2-Naphthalenesulfonamide,N-[2-[[3-[4-(aminomethyl)phenyl]propyl]amino]ethyl]-N-methyl-,dihydrochloride

2-Naphthalenol,6-[2-[[[4-[2-(dimethylamino)ethoxy]-3-fluorophenyl]methyl](1-methylethyl)amino]-4-methoxyphenyl]-5,6,7,8-tetrahydro-

2-Naphthalenol,6-[2-[[[4-[2-[bis(2-methoxyethyl)amino]ethoxy]phenyl]methyl](1-methylethyl)amino]-4-methoxyphenyl]-5,6,7,8-tetrahydro-

2-Quinoxalinecarboxylic acid, 3-methyl-,2-[(4-methylphenyl)sulfonyl]hydrazide, 1,4-dioxide

L-Proline,L-a-aspartyl-L-isoleucyl-L-tyrosyl-L-leucyl-L-a-glutamyl-L-valyl-L-isoleucyl-

2-Quinolinecarboxylic acid,4-hydroxy-8-(phenylmethoxy)-6-[3-(phenylmethoxy)-1-propynyl]-, methylester

2-Thiazolamine, 4-[2-methoxy-5-(1-methylethyl)phenyl]-

2-Quinolinecarboxylic acid, 8-nitro-4-phenyl-, methyl ester

2-Naphthalenesulfonamide,5-amino-6-hydroxy-N-[2-(tetradecyloxy)phenyl]-

2-Propanol, 1-[(diphenylmethyl)amino]-3-(2-methoxy-4-propylphenoxy)-,hydrochloride

2-Quinolinemethanol, a-(4-chlorophenyl)-, benzoate (ester)

2-Quinolinecarboxylic acid,4-(4-bromophenyl)-6-chloro-8-fluoro-1,2,3,4-tetrahydro-

2(3H)-Furanone,5-[(1R)-1-[bis(phenylmethyl)amino]-2-phenylethyl]dihydro-, (5S)-

Pyrido[3,2-d]pyrimidin-4(3H)-one,2-methyl-3-[4-[3-(1-piperidinyl)propoxy]phenyl]-

2-Naphthalenepropanoic acid, b-(2-bromophenyl)-

L-Proline, 4-mercapto-1-(2-naphthalenylsulfonyl)-,2-(4-methoxybenzoyl)-2-(phenylmethyl)hydrazide, (4R)-

61312-52-5 msds

CAS No 61312-52-5 supplier

CASNo 61312-52-5 distributor

CAS # 61312-52-5 manufacturer

CAS Number 61312-52-5 safety

CAS RN 61312-52-5 wholesale

2026-10-11 Find Butanoic acid, 3-oxo-, 1-(4-chlorophenyl)ethyl ester,CAS No.61312-52-5,Formula:C12H13ClO3 in 9CMX